JASPER THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
JASPER THERAPEUTICS, INC. (JSPR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 16.65 thousand shares for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2023-08-11
- JASPER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-09-30 was 57.06K shares.
- JASPER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-06-30 was 181.45K shares.
- JASPER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-03-31 was 24.11K shares.
- JASPER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2021-12-31 was 22.48K shares.
- JASPER THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 145.20K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2023-06-30 | 16.65K shares 10-Q · filed 2023-08-11 | |||
| 2022-09-30 | 57.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 238.51K shares derived: sum of 2 quarters · filed 2022-11-10 | 262.62K shares 10-Q · filed 2022-11-10 | 285.10K shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 181.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 205.56K shares 10-Q · filed 2022-08-12 | 228.04K shares derived: sum of 3 quarters · filed 2022-08-12 | |
| 2022-03-31 | 24.11K shares 10-Q · filed 2022-05-12 | 46.59K shares derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2021-12-31 | 22.48K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | 145.20K shares 10-K · filed 2022-03-18 | ||
| 2021-09-30 | 122.72K shares 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |